Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
in111-octreoscan (1 trial)
Ga 68 PSMA-11 (Illuccix) (1 trial)
gallium-68-dotatate (netspot) (1 trial)
lutetium dotatate lu-177 (Lutathera) (1 trial)
Carcinoma, Neuroendocrine (Phase 2)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 3)
Prostatic Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (4 total)